Lobbying on Evaluation economic adjustment programmes Greece.

Evaluation economic adjustment programmes Greece.

Economy, finance and the euro

The purpose of this evaluation is to assess the economic adjustment programmes for Greece (the intervention) which started in 2010 and ended in 2018 in order to draw lessons for future decision-making and identify areas of improvement for similar on-going or future possible interventions. The evaluation consists of an ex post assessment of the economic objectives, content and results of the programmes. The analysis will be primarily economic and based on data analysis.

Links

Public consultation

ID: 12145

Lobbying Activity

2 responses

Medicines for Europe: Greek pharma reforms failed to boost generics

MEDICINES FOR EUROPE, 29 Oct 2020

The organization argues that pharmaceutical reforms failed to achieve objectives like increasing generic penetration and controlling spending. They highlight that extreme price cuts and clawback mechanisms drove affordable medicines out while newer expensive products entered, and call for structural reforms addressing prescription control and unnecessary consumption of new medicines.

This would reduce their clawback payments and create a more predictable business environment for generic manufacturers.

Patients face higher out-of-pocket costs as affordable generics exit and expensive medicines dominate the market.

Consultation response

Panhellenic Union of Pharmaceutical Industry, 29 Oct 2020

Effectiveness: Regarding healthcare, the programmes imposed a significant decrease in healthcare spending (between 2009 and 2017) the total healthcare expenditure decreased by 36% and by 43% in the public expenditure. In 2017, the share of public funding in total healthcare expenditure was below…